Search for: "Myers Through Myers v. Price" Results 41 - 60 of 72
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Jul 2014, 12:22 pm by Rebecca Tushnet
People create expressive works through expressive labor. [read post]
12 Jan 2017, 7:01 am by John Elwood
National Association of Manufacturers v. [read post]
16 May 2008, 8:03 am
, (IPRoo), WIPO Director General candidates’ presentations to members: (Intellectual Property Watch), IP rights arise in UN debate on the right to participate in cultural life: (Intellectual Property Watch), IP academies agree to galvanise efforts to promote IP education: (WIPO), What business people do to maximise protection of IP: (Ezine @rticles), Lorin Brennan’s memo on interaction between UNICITRAL guide and IP rights: (IP finance), Kent’s… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
28 Jan 2013, 4:59 pm by VALL Blog Master
Choice, v.50, no. 06, February 2013. [read post]
19 Sep 2008, 6:00 pm
: (Techdirt), (Techdirt),   Pharma & Biotech Pharma & Biotech - General Biotech patent law: eleven key pending cases and future developments to watch: (Hal Wegner), (PatentDocs) Study by The Innovation Group highlights damaging intellectual property has been to biotech: (Techdirt), Drug regulatory agencies collaborate on counterfeits, new medical products: (Intellectual Property Watch), Canada: Health Canada releases summary report on industry consultations regarding… [read post]
8 Apr 2024, 10:08 am by admin
Dwyer, a young, earnest immunologist who had done some contract work on an unrelated matter for Bristol-Myers Squibb, a defendant in the litigation. [read post]
13 Nov 2009, 4:29 am
My thought: pursue the misuse arguments Posner offered in Ty v. [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
  These companies have historically been considered attractive targets for securities actions given the inherent risks of the industry and the volatility of their stock prices, and, as a result, often have relatively limited D&O insurance options. [read post]
3 Oct 2010, 11:01 pm by Mark Bennett
At Balkinization, guest blogger Sharon Dolovich explains why the Supreme Court’s Farmer v. [read post]
9 Sep 2011, 8:40 am by Peter Rost
"Ahead of these give-backs, they dramatically raise prices," Dr. [read post]
15 Feb 2012, 7:42 am by Peter Rost
"Ahead of these give-backs, they dramatically raise prices," Dr. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
"Ahead of these give-backs, they dramatically raise prices," Dr. [read post]
30 May 2012, 1:37 pm by Peter Rost
"Ahead of these give-backs, they dramatically raise prices," Dr. [read post]